Literature DB >> 19056166

Proteomic identification of tumor-associated protein in ovarian serous cystadenocarinoma.

Xiu-Qin Li1, Shu-Lan Zhang, Zhen Cai, Yuan Zhou, Tian-Min Ye, Jen-Fu Chiu.   

Abstract

Ovarian epithelial serous cystadenocarcinoma (OESC) is the most lethal of all gynecologic malignancies. In this report, we performed comparative proteomic study of normal ovarian epithelial and OESC tissue in order to establish OESC related protein atlas, and to identify tumor-associated proteins which may be important target proteins for clinical diagnosis and therapy and/or closely correlated to OESC pathogenesis. Six proteins were found significantly differentially expressed between normal ovarian epithelial and OESC tissues. The marked expression differences of selected proteins were further confirmed by Western blotting and immunohistochemistry. The correlation of prx-II expression with clinico-pathological features was also investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056166     DOI: 10.1016/j.canlet.2008.10.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Comparative secretome of ovarian serous carcinoma: Gelsolin in the spotlight.

Authors:  Sandra Pierredon; Pascale Ribaux; Jean-Christophe Tille; Patrick Petignat; Marie Cohen
Journal:  Oncol Lett       Date:  2017-04-25       Impact factor: 2.967

2.  Peroxiredoxin III protein expression is associated with platinum resistance in epithelial ovarian cancer.

Authors:  Xin-yan Wang; Hai-jiao Wang; Xiu-qin Li
Journal:  Tumour Biol       Date:  2013-04-06

3.  Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma.

Authors:  Ashlee L Smith; Mai Sun; Rohit Bhargava; Nicolas A Stewart; Melanie S Flint; William L Bigbee; Thomas C Krivak; Mary A Strange; Kristine L Cooper; Kristin K Zorn
Journal:  Proteomes       Date:  2013-10-17

Review 4.  Ovarian cancer: can proteomics give new insights for therapy and diagnosis?

Authors:  Angela Toss; Elisabetta De Matteis; Elena Rossi; Lara Della Casa; Anna Iannone; Massimo Federico; Laura Cortesi
Journal:  Int J Mol Sci       Date:  2013-04-15       Impact factor: 5.923

5.  The prognostic values of the peroxiredoxins family in ovarian cancer.

Authors:  Saisai Li; Xiaoli Hu; Miaomiao Ye; Xueqiong Zhu
Journal:  Biosci Rep       Date:  2018-09-05       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.